- Home
- Publications
- Publication Search
- Publication Details
Title
Dabigatran Etexilate
Authors
Keywords
-
Journal
CIRCULATION
Volume 123, Issue 13, Pages 1436-1450
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-04-05
DOI
10.1161/circulationaha.110.004424
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Coadministration of Dabigatran Etexilate and Atorvastatin
- (2013) Joachim Stangier et al. American Journal of Cardiovascular Drugs
- Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation
- (2013) Mark H. Eckman ANNALS OF INTERNAL MEDICINE
- Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
- (2013) James V. Freeman et al. ANNALS OF INTERNAL MEDICINE
- 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran)
- (2011) L. Samuel Wann et al. CIRCULATION
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban—Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study
- (2010) AMERICAN HEART JOURNAL
- Does Warfarin for Stroke Thromboprophylaxis Protect Against MI in Atrial Fibrillation Patients?
- (2010) Gregory Y.H. Lip et al. AMERICAN JOURNAL OF MEDICINE
- Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism
- (2010) Bengt I. Eriksson et al. Annual Review of Medicine
- Dabigatran: An Oral Novel Potent Reversible Nonpeptide Inhibitor of Thrombin
- (2010) Wolfgang G. Eisert et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- New Anticoagulants
- (2010) John W. Eikelboom et al. CIRCULATION
- Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate
- (2010) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- Dabigatran Acylglucuronide, the Major Human Metabolite of Dabigatran: In Vitro Formation, Stability, and Pharmacological Activity
- (2010) T. Ebner et al. DRUG METABOLISM AND DISPOSITION
- Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation
- (2010) Stephan H. Schirmer et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The frequency of prescription of P-glycoprotein-affecting drugs in atrial fibrillation
- (2010) L. JUNGBAUER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
- (2010) Lars Wallentin et al. LANCET
- Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial
- (2010) Hans-Christoph Diener et al. LANCET NEUROLOGY
- Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events
- (2010) Graeme J Hankey et al. LANCET NEUROLOGY
- Newly Identified Events in the RE-LY Trial
- (2010) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stroke Risk and Antithrombotic Strategies in Atrial Fibrillation
- (2010) Caroline Medi et al. STROKE
- Treatments for stroke prevention in atrial fibrillation: A network meta-analysis and indirect comparisons versus dabigatran etexilate
- (2010) Gregory Y. H. Lip et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
- (2010) Joachim Stangier et al. THROMBOSIS AND HAEMOSTASIS
- Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran
- (2009) Michael D. Ezekowitz et al. AMERICAN HEART JOURNAL
- Pharmacology, Pharmacokinetics, and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor
- (2009) Joachim Stangier et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly Subjects
- (2009) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery
- (2009) Sorrel E. Wolowacz et al. CLINICAL THERAPEUTICS
- Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends
- (2009) Jack CJ Sun et al. LANCET
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism in patients aged over 75 years or with moderate renal impairment undergoing total knee or hip replacement
- (2009) Neil Roskell et al. THROMBOSIS AND HAEMOSTASIS
- Ximelagatran increases membrane fluidity and changes membrane lipid composition in primary human hepatocytes
- (2009) Odile Sergent et al. TOXICOLOGY IN VITRO
- New Anticoagulants for Treatment of Venous Thromboembolism
- (2008) Peter L. Gross et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- New Antithrombotic Drugs
- (2008) Jeffrey I. Weitz et al. CHEST
- Pharmacology and Management of the Vitamin K Antagonists
- (2008) Jack Ansell et al. CHEST
- Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran Etexilate
- (2008) Joachim Stangier CLINICAL PHARMACOKINETICS
- Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development
- (2008) Bengt I Eriksson et al. CLINICAL PHARMACOKINETICS
- Oral Thrombin Inhibitor Dabigatran Etexilate vs North American Enoxaparin Regimen for Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery
- (2008) JOURNAL OF ARTHROPLASTY
- Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Are Not Affected by Moderate Hepatic Impairment
- (2008) Joachim Stangier et al. JOURNAL OF CLINICAL PHARMACOLOGY
- What do the results of the PRoFESS trial teach us?
- (2008) Graeme J Hankey et al. LANCET NEUROLOGY
- Dabigatran Etexilate: An Oral Direct Thrombin Inhibitor for Prophylaxis and Treatment of Thromboembolic Diseases
- (2008) Brooke E Baetz et al. PHARMACOTHERAPY
- Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty
- (2008) Neil Roskell et al. THROMBOSIS AND HAEMOSTASIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More